Latest News and Press Releases

Pressmeddelande 3 december 2021 Immunicum tillkännager avslutad Fas Ib och tidig stängning av ILIAD-studienImmunicum AB (“Immunicum”, publ; IMMU.ST), ett bioläkemedelsföretag fokuserat på...

Press Release  Stockholm, Sweden, December 3, 2021 Immunicum Announces Completion of Phase Ib Portion and Early Closure of ILIAD Study Immunicum AB (“Immunicum”, publ; IMMU.ST), a biopharmaceutical...

Pressmeddelande 27 augusti 2021 Immunicum tillkännager deltagande i flera kommande bransch- och investerarmöten i september och oktober Immunicum AB (publ) meddelade idag att man kommer att...

Press Release 27 August 2021 Immunicum Announces Participation in Multiple Upcoming Industry and Investor Events in September and October Immunicum AB (publ) today announced that it...

Pressmeddelande 26 August 2021 Immunicum AB (publ) April – Juni 2021 i Sammandrag  Nettoomsättning för kvartalet uppgick till - (-).Periodens resultat uppgick till KSEK -31,278...

Press Release 26 August 2021 Immunicum AB (publ) Interim Report April - June 2021 FINANCIAL SUMMARY FOR THE QUARTER APRIL - JUNE Net sales for the period amounted to -...

Press Release 26 July 2021  Immunicum tillkännager positiv granskning från Data Safety Monitoring Board av fas Ib IILIAD-studien -- Independent Data Safety and Monitoring Board (DSMB) har avgivit...

Press Release 26 July 2021 Immunicum Announces Positive Review by Data Safety Monitoring Board for Phase Ib Part of ILIAD Study  -- Independent Data Safety and Monitoring Board (DSMB) issues...

Pressrelease 12 maj 2021 Immunicum håller presentationer vid European Hematology Association (EHA) 2021 Virtual Congress Immunicum AB (publ; IMMU.ST) tillkännagav idag att bolaget kommer att...

Press Release 12 May 2021 Immunicum Announces Presentations at the European Hematology Association (EHA) 2021 Virtual Congress Immunicum AB (publ; IMMU.ST) today announced that it will be...